OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 24.05.2026, 13:27

Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

Economic Analysis on Healthcare Costs with AI

2026·0 Zitationen·OPUS - Open Portal to University Scholarship (Governors State University)
Volltext beim Verlag öffnen

0

Zitationen

1

Autoren

2026

Jahr

Abstract

This research paper analyzes rising healthcare costs in the United States through core economic concepts in public administration, including market failure, public goods theory, externalities, cost-benefit analysis, and price elasticity. These frameworks explain persistent inefficiencies such as information asymmetry between providers and patients, high administrative expenses, limited price transparency, and restricted competition among healthcare systems and pharmaceutical companies. The paper integrates the growing role of Artificial Intelligence (AI) as both a response to and driver of economic change in healthcare. AI technologies—including predictive analytics, automated claims processing, and clinical decision-support systems—have the potential to reduce administrative waste, improve diagnostic accuracy, and strengthen resource allocation. By lowering transaction costs and enhancing data transparency, AI may partially address information asymmetry and improve cost-benefit outcomes across public programs. However, AI also introduces new economic and governance challenges. High development costs, data concentration, and network effects may reinforce market consolidation among dominant firms. Additionally, algorithmic bias risks exacerbating health disparities, creating negative externalities that disproportionately affect marginalized populations. These concerns highlight the need for regulatory oversight and equity-centered implementation. The paper evaluates major government interventions such as the Affordable Care Act, Medicare, and Medicaid, assessing how these policies address structural market failures and how AI integration within public programs may enhance efficiency and fraud prevention. Drawing on lessons from the COVID-19 pandemic and prescription drug pricing debates, the analysis concludes that while AI offers cost-containment potential, meaningful reform requires coordinated economic policy, competition safeguards, and ethical governance to achieve a more equitable and sustainable healthcare system.

Ähnliche Arbeiten

Autoren

Institutionen

Themen

Artificial Intelligence in Healthcare and EducationHealthcare Policy and ManagementEthics and Social Impacts of AI
Volltext beim Verlag öffnen